Skip to main content
. Author manuscript; available in PMC: 2025 Aug 25.
Published in final edited form as: ChemMedChem. 2023 Sep 4;18(18):e202300331. doi: 10.1002/cmdc.202300331

Table 2.

Compilation of selected literature reports on the involvement on the expression and functions of the lysyl oxidase isozymes LOX and LOXL2 in selected tumour entities of various origins.

Tumour entity isoform reference
Breast cancer LOX [53]
LOXL2 [50c, 54]
Lung cancer LOX [55]
LOXL2 [56]
Colorectal carcinoma LOX [57]
LOXL2 [58]
Pancreatic carcinoma LOX [59]
LOXL2 [59a, 60]
Gastric cancer LOX [51b]
LOXL2 [61]
Prostate cancer LOX [62]
LOXL2 [63]
Glioma LOX [64]
LOXL2 [65]
Head /neck tumours (squamous cell type) LOX [66]
LOXL2 [67]
Hepatocellular carcinoma LOX [68]
LOXL2 [69]
Skin cancer (w/o melanoma) LOX [70]
LOXL2 [56a]